CDC Updates Practice Recommendations for Contraceptives
By Elana Gotkine HealthDay Reporter
FRIDAY, Aug. 9, 2024 -- In two practice recommendations published in the Aug. 8 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report, updated recommendations are presented relating to use of specific contraceptive methods and for persons with certain characteristics or medical conditions.
Kathryn M. Curtis, Ph.D., from the CDC in Atlanta, and colleagues updated recommendations for health care providers relating to initiation and use of specific contraceptive methods after a review of the evidence. The updates include recommendations for provision of medications for intrauterine device placement; recommendations for bleeding irregularities during use of implants; recommendations for use of testosterone and risk for pregnancy; and recommendations for injectable contraception self-administration.
Antoinette T. Nguyen, M.D., also from the CDC, and colleagues updated recommendations for the use of specific contraceptive methods by persons with certain characteristics or medical conditions. Updates include the addition of recommendations for individuals with chronic kidney disease; revisions to the recommendations for persons with specific characteristics or conditions, including breastfeeding, postpartum, obesity, surgery, high risk for HIV infection, cirrhosis, liver tumor, sickle cell disease, and solid organ transplantation; and inclusion of new contraceptive methods, such as new combined oral contraceptives, contraceptive patches, vaginal rings, progestin-only pills, levonorgestrel intrauterine devices, and vaginal pH modulators.
"Voluntary informed choice of contraceptive methods is an essential guiding principle of these recommendations, and person-centered contraceptive counseling can help to ensure a person's contraceptive needs are met successfully," Nguyen and colleagues write.
U.S. Selected Practice Recommendations for Contraceptive Use, 2024
U.S. Medical Eligibility Criteria for Contraceptive Use, 2024
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted August 2024
Read this next
Inflammation in Childhood Linked to Onset of Mental Health Disorders
FRIDAY, Aug. 23, 2024 -- Low-grade systemic inflammation across childhood and adolescence is associated with the subsequent onset of mental health disorders, according to a study...
Two-Thirds of COPD Hospitalized Patients Misuse Inhalers
FRIDAY, Aug. 23, 2024 -- Among patients hospitalized with a diagnosis of chronic obstructive pulmonary disorder (COPD), two-thirds of inhalers assessed at admission are misused...
Salivary CD44, Total Protein ID Recurrence Risk in Head and Neck Cancer
THURSDAY, Aug. 22, 2024 -- Elevated salivary levels of CD44 and total protein (TP) can identify head and neck cancer patients with an increased risk for cancer recurrence...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.